Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (321-330 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology|December 15, 2016
Alterations in B-cell subsets in pediatric patients with early atopic dermatitisTali Czarnowicki, Hitokazu Esaki, Juana Gonzalez, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2019
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitisEmma Guttman-Yassky, Ana B Pavel, Lisa Zhou, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
Allergy|November 20, 2023
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 studyRobert Bissonnette, Janet DuBois, Paola Facheris, et al.
The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.
Journal of the American Academy of Dermatology|February 18, 2021
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)Eric L Simpson, Seth Forman, Jonathan I Silverberg, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2016
A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitisPatrick M Brunner, Saakshi Khattri, Sandra Garcet, et al.
Allergy|July 29, 2021
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years oldIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|February 4, 2021
EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitisIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
The Journal of Allergy and Clinical Immunology|August 6, 2019
Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitisKenji Sakurai, Teruki Dainichi, Sandra Garcet, et al.
Pageof 39

Showing results (321-330 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology|December 15, 2016
Alterations in B-cell subsets in pediatric patients with early atopic dermatitisTali Czarnowicki, Hitokazu Esaki, Juana Gonzalez, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2019
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitisEmma Guttman-Yassky, Ana B Pavel, Lisa Zhou, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
Allergy|November 20, 2023
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 studyRobert Bissonnette, Janet DuBois, Paola Facheris, et al.
The Journal of Allergy and Clinical Immunology|January 28, 2019
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitisLisa Zhou, Alexandra Leonard, Ana B Pavel, et al.
Journal of the American Academy of Dermatology|February 18, 2021
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)Eric L Simpson, Seth Forman, Jonathan I Silverberg, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2016
A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitisPatrick M Brunner, Saakshi Khattri, Sandra Garcet, et al.
Allergy|July 29, 2021
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years oldIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|February 4, 2021
EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitisIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
The Journal of Allergy and Clinical Immunology|August 6, 2019
Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitisKenji Sakurai, Teruki Dainichi, Sandra Garcet, et al.
Pageof 39